Monday, September 14, 2026

Defense Minister Shin: No Threat to U.S.-South Korea Alliance Despite North Korean ICBMs

On the 22nd, Minister of National Defense Shin Won Sik stated, "Even if North Korea deploys Intercontinental Ballistic Missiles (ICBM) in the field...

Meta and Google Found Guilty: 6.3 Million USD Verdict for Social Media Addiction Impact on Youth

Meta and Google were found guilty of designing harmful social media for youth, ordered to pay damages, and face more lawsuits ahead.

DILUSIONAL Peace: North Korea FIRES Missiles, But South Korea Sees A ‘Stronger Spark’ For Dialogue

Trump's overtures to North Korea signal a potential thaw in relations, despite the recent failed APEC meeting and missile tests.

Tag: industry

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Celltrion’s CT-P51: Will This Keytruda Biosimilar Disrupt the 44 Billion USD Cancer Drug Market?

Celltrion has applied for approval of its biosimilar CT-P51 for the global blockbuster immuno-oncology drug Keytruda (pembrolizumab).

How the New BINSA Law Will Transform K-Bio: Opportunities and Challenges for Korean Companies

U.S. Congress is pushing for investment regulations targeting China's biotech industry, impacting global supply chains and local firms.

Celltrion Expands Market Presence With Major Tender Wins in Spain and Portugal

Celltrion is accelerating its expansion in Spain and Portugal through major tender wins, rising prescriptions and a strengthened direct-sales strategy across its biosimilar portfolio.

How AI and ICT Companies Can Break into the Space Industry: Key Insights from the 9th Aerospace SOS Meeting

The Aerospace Agency is developing policies to encourage AI and ICT companies to enter the space industry, focusing on space data technology.

Samsung Bioepis, Built on Biosimilars, Expands Growth Strategy Into Novel Drugs

Samsung Bioepis is pursuing a two-track growth strategy that combines global biosimilar expansion with next-generation novel drug development, including ADC therapies.

Beyond Approval to Insurance Coverage: Medical AI Companies Turn to Real-World Evidence to Drive Adoption

The focus of the medical AI industry is shifting from technology development to integration in healthcare settings.

Unlocking Growth: How Biopharmaceuticals’ Cenobamate is Transforming Epilepsy Treatment in Asia

SK Biopharmaceuticals' epilepsy drug Cenobamate is expected to continue its growth trend in the second half of the year.

FDA Adjusts Drug Review Fees: Higher for New Drugs, Lower for Generics

The FDA’s 2027 fee changes lower review costs for new drugs and biosimilars while raising fees for generics and medical devices, with the impact varying by company.

PenetriumBioScience Files U.S. FDA IND for Phase 2a Trial in Advanced Solid Tumors

Penitrium Bioscience enters Phase 2a clinical trials in the U.S. for its cancer drug candidate 'Penitrium.'

Unlocking AI Performance: Samsung’s zHBM vs. SK Hynix’s HBF – Which Memory Solution Reigns Supreme?

Samsung and SK Hynix unveil next-gen memory, showcasing their advanced technology and competitive edge in the industry.

Huawei Unveils OpenPangu 2.0 Pro: Is This the Future of AI with 505 Billion Parameters?

Huawei accelerates its AI ecosystem expansion by revealing the source of its massive AI model with over 500 billion parameters.

Samsung and SK Hynix: How AI is Revolutionizing Shareholder Returns in 2026

Samsung and SK Hynix, benefiting from the AI memory supercycle, are expanding shareholder returns, signaling changes in semiconductor capital policies.

How DIDEN Robotics is Revolutionizing Shipbuilding with the DIDEN Spider Robot

Diden Robotics seeks 100 billion KRW to expand its quadrupedal robot, the Diden Spider, targeting shipbuilding and humanoid robot markets.

Samsung Heavy Industries Strengthens U.S. Shipbuilding Ties with LNG Bunker Vessel Certification

Samsung Heavy Industries strengthens U.S. partnerships with agreements on LNG vessels, AI research, and training initiatives at KUSPC.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.